LONDON, England, Jan. 28 (TNSjou) -- The Institute of Cancer Research issued the following news on Jan. 27, 2026:

* * *

Study sets out clear recommendations for patient-reported outcomes in early cancer drug trials

New research presents clear guidelines on how patient-reported outcomes (PROs) can be used more effectively in early-stage cancer drug trials, helping ensure that patient experiences meaningfully inform treatment decisions around dosing.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:

What's your Affiliation

Government Newspaper / Media Business Public Policy Individual / Student Educators

Email:

Phone:

Organization, if any:

State/Country you are in:

Additional questions or comments:

Submit Form Click here for more information about our products